I Aced Every Cardiac Test. I Still Had an 80% Blockage.

I run 12-lead ECGs on patients every shift in the ER at Mayo Clinic. Mine came back textbook. So did my echo. So did my Holter. Every standard test said my heart was fine. Meanwhile, the major cardiology guidelines, the ACC, AHA, ESC, and NICE, had already moved toward a different first test for stable chest pain like mine: a CT coronary angiography, a CCTA, the scan that actually looks inside the arteries of your heart. Not a stress test. Not an echo. I had to push to get one. It found an 80% blockage in my right coronary artery. The fight to get that scan ordered is its own story, and it is next week's post. This one is about the part that still unsettles me: how I passed the entire standard cardiac workup with a severe, flow-limiting blockage sitting in my artery the whole time.

Last week I walked through the study the keto community relied on to claim that sky-high LDL doesn't cause plaque, and how the follow-up data got retracted for uncorrectable methodological problems. That post was about the science I trusted. This one is about the tests I trusted.

Because here's the thing that haunts me most about my own case: even after the diet question came into focus, every standard cardiac test told me I was fine. The science was wrong about LDL being benign. And the screening system was blind to the damage it caused.

The Bottom Line: A normal ECG, echo, Holter, or stress test can be genuinely reassuring, but only for the question each one was built to answer: is the rhythm stable, is the muscle pumping, is the heart starved for blood right now. None of them proves your coronary arteries are clean. They read the heart's electrical activity, its structure, and how it behaves under stress. They do not map the plaque sitting inside the artery wall. That distinction is the blind spot that nearly killed me, and it is the one most patients never hear.

The Clean Sweep

In the weeks before I was diagnosed with an 80% blockage of my right coronary artery, I ran through a cardiac workup at a major academic medical center. I didn't just pass. I aced it.

My 12-lead ECG showed normal sinus rhythm. I run these all day in the ER. I know what a clean tracing looks like, and mine was textbook. My echocardiogram came back with normal wall motion, normal ejection fraction, no structural abnormalities. My Holter monitor tracked my heart rhythm for 48 hours and came back unremarkable outside of a very minimal burden of PVCs (premature ventricular contractions), which are sometimes felt as skipped beats, or contractions, and are usually harmless if only seen in small numbers. My Apple Watch and Oura Ring had never flagged a single abnormal reading. Resting heart rate in the low 50s. Labs to look for things like lipoprotein(a), a genetic risk factor for heart disease, were negative. So were other less-tested markers like homocysteine. My inflammation was fine, with a rock-bottom CRP. And as mentioned in other posts, no insulin resistance per hemoglobin A1c testing and my own experimentation with a continuous glucose monitor.

Every test said I was fine. Every metric pointed to a healthy heart in a healthy 44-year-old.

A few weeks later, I was pulling over on an interstate after reading a critical result on my phone: severe, flow-limiting occlusion of my right coronary artery. An 80% blockage. The interventional cardiologist told me only a few blood cells at a time were squeezing past it. I was one bad day away from a heart attack.

How does that happen? How does someone pass every standard cardiac test and still have severe coronary artery disease?

The answer isn't complicated. It's just uncomfortable: those tests weren't designed to find what was killing me.

What These Tests Actually Do (and Don't)

A 12-lead ECG records the electrical activity of your heart over about 10 seconds. It's a snapshot. It can detect arrhythmias, signs of an active heart attack, and sometimes evidence of a prior one. I use it dozens of times per shift. What it cannot do is see plaque inside your coronary arteries.

If the heart muscle is getting adequate blood flow at rest, the tracing looks normal. An artery can be 80 percent blocked and still deliver enough blood at rest to keep the electrical pattern clean.

Mahmoodzadeh et al. compared resting ECG findings against coronary angiography (the gold standard, where they thread a catheter in and look directly at the arteries) and found an overall sensitivity of just 51.5%.¹ In plain terms, that means the ECG missed nearly half of all real coronary disease cases. For the right coronary artery, the one that was 80% blocked in mine, the detection rate was just 25.8%.¹

The test most people think of as "checking your heart" catches a right coronary blockage about one in four times.

An echocardiogram uses ultrasound to look at your heart's structure and function: chamber sizes, valve function, how the muscle is contracting. It's the gold standard for structural heart disease. It is not a coronary artery test.

A resting echo looks at whether the heart muscle is moving properly. But if the coronary arteries are slowly narrowing and the muscle hasn't yet been starved enough to sustain visible damage, the walls look fine. The ejection fraction (the percentage of blood the heart pumps out with each beat) looks fine. Everything looks fine. The echo can't see the disease until the disease has already done serious damage.

My echo was pristine because my heart muscle was still being perfused, barely. The RCA was 80% blocked, but the remaining 20% was enough to keep the muscle alive and contracting normally at rest. The echo looked at the muscle and said "all good." It never looked at the artery.

A Holter monitor records your heart rhythm continuously over 24 to 48 hours. It's built to catch arrhythmias and rhythm abnormalities that might not show up on a 10-second ECG. It can also pick up signs of ischemia (when the heart muscle isn't getting enough blood), but only if that ischemia happens to occur during the monitoring window.² Mine was unremarkable because during those 48 hours, my blockage wasn't causing enough oxygen deprivation to trigger a detectable change. The disease was there. It just wasn't declaring itself.

Ischemia vs. Anatomy: The Blind Spot

This is the distinction that explains my case, and it's the one most patients never hear.

All traditional cardiac testing (ECGs, echos, Holters, stress tests) is built around one question: Is the heart muscle getting enough blood right now? That's called testing for ischemia. You stress the heart and look for signs that blood flow isn't keeping up with demand.

But that's not the same as asking: What do the arteries actually look like?

An 80% blockage can be compensated. The body can grow small detour vessels around the blockage, or the geometry of the narrowing might preserve enough flow. The stress test comes back normal. The plaque is still there.

The resting-ECG numbers are bad enough. But even exercise stress testing (where you're on a treadmill pushing your heart rate up) doesn't close the gap. A 2012 systematic review of 34 studies by Banerjee et al. found that exercise testing is better at ruling coronary disease out than ruling it in, and that for a standard treadmill ECG, a normal result only modestly lowers the odds that real disease is there.³ A clean stress test can still sit on top of significant plaque. For the condition that kills more people than anything else on the planet, that should bother all of us.

And none of these tests can tell you anything about what kind of plaque you have, whether it's calcified and stable, or soft and vulnerable to rupture. They detect the downstream consequence (ischemia) rather than the upstream cause (atherosclerosis). The entire traditional workup asks whether the heart is struggling right now. It never asks whether the arteries are diseased.

The Scale of What We're Missing

Here's where this stops being about my case and starts being about yours.

The PESA study imaged 4,184 asymptomatic adults aged 40 to 54 with no history of cardiovascular disease. These were bank employees in Madrid, middle-aged, apparently healthy people living normal lives.⁴

Sixty-three percent of them already had subclinical atherosclerosis, silent plaque building somewhere in their arteries. To be precise about what that means: PESA looked across several arterial beds, the carotids, the abdominal aorta, the leg arteries, and the coronaries, not the coronary arteries alone. The point isn't that 63% had a hidden coronary blockage. It's that by midlife, silent arterial disease was already the norm rather than the exception, in people a standard workup would have waved straight through. Among the men it was 71%, and even among the participants flagged as low 10-year risk by standard calculators, 58% already had disease.⁴

Patel et al. examined 398,978 patients without known coronary artery disease who were referred for elective coronary angiography, the invasive test where they thread a catheter in to look directly.⁵ Only 37.6% turned out to have obstructive disease. That doesn't mean every prior test failed. It means the old pathway was a blunt instrument for deciding whose arteries were actually worth looking at directly.

What Actually Looks at the Arteries

There are two tests that look directly at your coronary arteries for plaque.

Coronary artery calcium (CAC) scoring uses a non-contrast CT scan to quantify calcified (hardened) plaque in the coronary arteries. It's fast, relatively cheap, and low radiation. A score of zero is associated with very low short-term cardiovascular risk.⁶

But a zero doesn't mean your arteries are clean. Osborne-Grinter et al. analyzed data from the SCOT-HEART trial and found that among patients with a calcium score of zero, 14% still had non-obstructive disease and 2% had obstructive disease on CT angiography.⁷ Sama et al. confirmed in a 2024 meta-analysis that approximately 10% of asymptomatic patients with zero calcium scores have non-calcified plaque.⁸ The calcium score only sees hard plaque. It misses the soft plaque, the kind that can rupture. My own case makes the point: the majority of my RCA occlusion was not calcified. A calcium score alone might have missed it.

CT coronary angiography (CCTA) uses contrast dye and a CT scanner to create detailed images of the coronary arteries. It can see both calcified and non-calcified plaque, measure how much narrowing there is, and flag features that suggest higher-risk plaque. It is not a microscope, and it can't tell you everything about a plaque's biology, but compared with a calcium score it shows the artery itself: the narrowing, the calcified plaque, and the soft plaque a calcium scan can't see. In patients evaluated for suspected coronary disease, the ACCURACY trial demonstrated 95% sensitivity and a 99% negative predictive value, meaning if the CCTA says your arteries are clean, they're almost certainly clean.⁹

The outcomes data is now hard to argue with. The SCOT-HEART trial followed 4,146 patients for 10 years and found the group who got a CCTA had fewer non-fatal heart attacks: 4.3% versus 6.0%.¹⁰ The benefit didn't come from more procedures. Revascularization rates were essentially identical, 15.2% versus 15.3%. The more plausible read is that when doctors could actually see the plaque, they acted on it: starting statins, escalating prevention, and patients took it more seriously. Preventive-therapy prescribing stayed higher in the CCTA group years later. Seeing the disease changed what people did about it. That's a 10-year reduction in heart attacks that traces not to more stents, but to better information.

A caveat, because the honest-broker version matters here: this is not an argument that everyone with chest discomfort needs a CT scan. When the question is "is my heart struggling under stress right now?", a functional test can answer it, and the PROMISE trial found that for stable, low-to-intermediate-risk chest pain, an anatomy-first CCTA strategy did not produce better outcomes than functional testing.¹¹ The DISCHARGE trial found that for stable chest pain at intermediate risk, CT and invasive angiography led to similar rates of major cardiac events, with fewer procedure-related complications in the CT group.¹² The point isn't that CCTA wins every time. It's that anatomy and function are different questions, and a workup that answered everything except the anatomy question is exactly how someone like me gets reassured right up until the scan that changes everything.

The Guideline-Practice Gap

Here's where I get angry. Not at my cardiologist. At the system.

In 2021, the ACC and AHA published updated chest pain guidelines that gave CCTA a Class 1 recommendation, the strongest category in medicine, the one reserved for situations where the benefit clearly outweighs the risk and the evidence is strong, as a first-line test for symptomatic patients at intermediate-to-high risk without known coronary artery disease.¹³ That was me: middle-aged, with symptoms, no prior cardiac history. In 2024, the European Society of Cardiology reached the same conclusion.¹⁴ The UK figured this out even earlier: NICE recommended CCTA as the first-line test for new, suspected cardiac chest pain back in 2016.¹⁵

So by the time I sat in a cardiology office, the major guideline societies had already pointed in the same direction: for a patient like me, the first look should be a CCTA. Not an EKG. Not an echo. Not a Holter. A CCTA.

I got an EKG, an echo, and a Holter first.

This is not about blaming individual doctors. My cardiologist is a skilled clinician, and the stepwise approach he used was the standard of care for decades. The problem is that the evidence moved, the guidelines moved, and everyday practice didn't move with them. That happens in medicine more than any of us want to admit. And if it can happen at a major academic medical center, think about what's happening in community cardiology practices and small rural towns without a cardiac CT scanner within 50 miles.

The barriers are real: reimbursement was low enough that CMS increased CCTA payment in 2025, there's a widely reported shortage of physicians trained to read cardiac CT, and nuclear stress testing has massive installed infrastructure that institutions don't abandon overnight. But none of those barriers change what the evidence says. And none of them should be invisible to the patient sitting in the exam room.

When the Symptoms Don't Match the Textbook

The blind spots aren't only in the machines. They're in the assumptions about what a heart attack is supposed to look like. I've watched women come into the ER in the middle of a STEMI, an ST-elevation myocardial infarction, the kind where a coronary artery is usually fully blocked. AKA, a heart attack. And they walked in with none of the textbook signs. No crushing chest pain. Nothing radiating to the jaw or down the arm. No obvious shortness of breath. The complaint was that they felt dizzy. Or lightheaded. Or just wiped out and exhausted.

Here's the part that should bother you, and it's something I live every shift. When a patient reports chest pain, the response is fast and automatic: a 12-lead ECG within 10 minutes of walking through the door, because that tracing is how we catch a STEMI in progress. But if chest pain isn't the complaint, that clock often never starts. No reported chest pain, no immediate ECG, and a heart attack that is actively happening can go unseen in the one room built to catch it.

This isn't just my read from the floor. A registry analysis of more than a million heart attack patients found that 42% of women presented without chest pain, compared with 30.7% of men. And among the younger patients, the women who showed up without chest pain were more likely to die in the hospital than the men who showed up the same way.¹⁶ The pattern medicine is trained to recognize is the pattern that shows up more reliably in men.

None of this means every dizzy spell is a heart attack. It means "it doesn't feel like the textbook" is not the same thing as "it isn't my heart."

What This Means For You

If you're in your 30s, 40s, or 50s. If you've been told your cholesterol is "borderline" but not worth treating. If you've had vague chest symptoms that were chalked up to anxiety. If you've passed a standard cardiac workup and been told your heart looks great, consider what that workup actually tested.

A clean 12-lead means your heart's electrical system is working. A clean echo means your heart muscle is contracting properly. A clean Holter means your rhythm was stable. None of those tests looked inside your coronary arteries for plaque.

If you have risk factors, things like elevated LDL, family history, or prior smoking, and you want to know whether plaque is forming, talk to your doctor about a coronary artery calcium score as a starting point. If there's clinical suspicion or risk factors that warrant it, ask about a CCTA. And if your doctor suggests a stress test first, it's worth asking: "The current ACC/AHA guidelines recommend CCTA as first-line for symptomatic patients without known CAD. Can we discuss whether that applies to me?"

You shouldn't have to know that. But right now, you might need to.

I had every advantage: clinical vocabulary, ER experience, a cardiologist at Mayo Clinic. And it still took every ounce of that advantage to get the test that found my disease. But getting the test was only half the fight. The other half was getting my cardiologist to order it in the first place.

That's next week's post.

References

1. Mahmoodzadeh S, Moazenzadeh M, Rashidinejad H, Sheikhvatan M. Diagnostic performance of electrocardiography in the assessment of significant coronary artery disease and its anatomical size in comparison with coronary angiography. J Res Med Sci. 2011;16(6):750-755. PMID: 22091303

2. Stone PH. ST-segment analysis in ambulatory ECG (AECG or Holter) monitoring in patients with coronary artery disease: clinical significance and analytic techniques. Ann Noninvasive Electrocardiol. 2005;10(2):263-278. PMID: 15842439

3. Banerjee A, Newman DR, Van den Bruel A, Heneghan C. Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies. Int J Clin Pract. 2012;66(5):477-492. PMID: 22512607

4. Fernández-Friera L, Peñalvo JL, Fernández-Ortiz A, et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104-2113. PMID: 25882487

5. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886-895. PMID: 20220183

6. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72(4):434-447. PMID: 30025580

7. Osborne-Grinter M, Kwiecinski J, Doris M, et al. Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial. Eur Heart J Cardiovasc Imaging. 2022;23(9):1210-1221. PMID: 34529050

8. Sama C, Abdelhaleem A, Velu D, et al. Non-calcified plaque in asymptomatic patients with zero coronary artery calcium score: a systematic review and meta-analysis. J Cardiovasc Comput Tomogr. 2024;18(1):43-49. PMID: 37821352

9. Budoff MJ, Dowe D, Jollis JG, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY trial. J Am Coll Cardiol. 2008;52(21):1724-1732. PMID: 19007693

10. Williams MC, Wereski R, Tuck C, et al. (SCOT-HEART Investigators). Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland. Lancet. 2025;405(10475):329-337. DOI: 10.1016/S0140-6736(24)02679-5 PMID: 39863372

11. Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease (PROMISE). N Engl J Med. 2015;372(14):1291-1300. DOI: 10.1056/NEJMoa1415516 PMID: 25773919

12. Maurovich-Horvat P, Bosserdt M, Kofoed KF, et al. CT or Invasive Coronary Angiography in Stable Chest Pain (DISCHARGE). N Engl J Med. 2022;386(17):1591-1602. DOI: 10.1056/NEJMoa2200963 PMID: 35240010

13. Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. Circulation. 2021. DOI: 10.1161/CIR.0000000000001029 PMID: 34709879

14. 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes. European Heart Journal. 2024;45(36):3415. PMID: 39210710

15. National Institute for Health and Care Excellence. Chest pain of recent onset: assessment and diagnosis. Clinical guideline CG95. Published 2010, updated 2016. Available at: https://www.nice.org.uk/guidance/cg95.

16. Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307(8):813-822. DOI: 10.1001/jama.2012.199 PMID: 22357832